Oryzon Genomics S.A.
Balance Sheet
Last updated:
The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has Oryzon Genomics S.A.'s balance sheet done over the years? Its assets were worth $118,017,369 last year, which is more than in the previous period. 24% of Oryzon Genomics S.A.’s total assets is currently financed by debt. Its liabilities reached the amount of $27,738,459, which means an decrease by -17% compared compared to last year.
Debt to Assets
| 2014 | 31541194 | 14.72M | 46.68% |
|---|---|---|---|
| 2015 | 44236644 | 14.26M | 32.26% |
| 2016 | 0 | 27.01M | Infinity% |
| 2017 | 73237836 | 31.92M | 43.59% |
| 2018 | 0 | 22.32M | Infinity% |
| 2019 | 89842611 | 21.27M | 23.68% |
| 2020 | 114960594 | 22.20M | 19.31% |
| 2021 | 108564101 | 27.45M | 25.29% |
| 2022 | 111039575 | 33.33M | 30.02% |
| 2023 | 118017369 | 27.73M | 23.5% |
0RDB.L Balance Sheet (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets: | ||||||||||
Cash and cash equivalents | 13.53M | 22.82M | 32.69M | 48.38M | 39.38M | 34.31M | 41.93M | 22.02M | 21.14M | 4.39M |
Short term investments | 0 | 0 | 0 | 0 | 158.78K | 556 | 255.76K | 5.24M | 2.45M | 6.82M |
Net receivables | 0 | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 87.54K |
Inventory | 6.65K | 10.49K | 118.13K | 387.04K | 323.95K | 134.50K | 8.72K | 8.33K | 4.27K | 10.82K |
Other current assets | 2.22M | 4.10M | 4.29M | 2.99M | 2.46M | 0 | 1.15M | 0 | 1.03M | 779.28K |
Total current assets | 15.76M | 26.94M | 37.11M | 51.76M | 42.33M | 35.66M | 43.34M | 28.47M | 24.63M | 12.10M |
Non-current assets: | ||||||||||
Property, Plant and Equipment | 531.34K | 654.69K | 776.71K | 786.61K | 708.11K | 664.90K | 765.78K | 695.87K | 927.02K | 1.18M |
Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Intangible assets | 420.95K | 557.25K | 717.50K | 253.59K | 505.09K | 119.85K | 34.25K | 24.27K | 20.37K | 38.38K |
Long term investments | 0 | 0 | 0 | 49.84K | 45.76K | 40.8K | 49.19K | 41K | 373.92K | 611.95K |
Other non-current assets | 101.30M | 82.88M | 69.95M | 62.10M | 46.25M | -825.56K | 29.04M | -761.14K | 18.28M | 17.60M |
Total non-current assets | 102.25M | 84.09M | 71.45M | 63.19M | 47.51M | 825.56K | 29.89M | 761.14K | 19.60M | 19.43M |
Total assets | 118.01M | 111.03M | 108.56M | 114.96M | 89.84M | 0 | 73.23M | 0 | 44.23M | 31.54M |
Liabilities | ||||||||||
| Current liabilities: | ||||||||||
Accounts payable | ||||||||||
Deferred revenue | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Short term debt | 13.18M | 13.03M | 4.74M | 5.92M | 7.34M | 0 | 8.82M | 0 | 3.14M | 3.23M |
Total current liabilities | 18.12M | 20.05M | 9.86M | 9.39M | 11.82M | 10.44M | 10.43M | 7.59M | 5.75M | 4.80M |
| Non-current liabilities: | ||||||||||
Long term debt | 6.99M | 11.07M | 15.19M | 10.60M | 7.51M | 9.97M | 19.24M | 17.72M | 6.70M | 7.77M |
Deferred tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other non-current liabilities | 2.62M | 2.19M | 2.38M | 2.20M | 1.93M | -9.97M | 2.24M | -17.72M | 1.80M | 2.14M |
Total non-current liabilities | 9.61M | 13.27M | 17.58M | 12.80M | 9.44M | 9.97M | 21.49M | 17.72M | 8.51M | 9.92M |
Total liabilities | 27.73M | 33.33M | 27.45M | 22.20M | 21.27M | 22.32M | 31.92M | 27.01M | 14.26M | 14.72M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |